Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin

被引：4

作者：

Cho, Hundo ^{[1
]}

Choi, Jin-Hyuk ^{[1
]}

Kang, Seok Yun ^{[1
]}

Lee, Hyun Woo ^{[1
]}

Choi, Yong Won ^{[1
]}

Kim, Tae-Hwan ^{[1
]}

Ahn, Mi Sun ^{[1
]}

Kim, Chul-Ho ^{[2
]}

Shin, Yoo Seob ^{[2
]}

Jang, Jeon Yeob ^{[2
]}

Oh, Young-Taek ^{[3
]}

Heo, Jaesung ^{[3
]}

Sheen, Seung Soo ^{[4
]}

机构：

[1] Ajou Univ, Sch Med, Dept Hematol Oncol, 164 World Cup Ro, Suwon 16499, South Korea

[2] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon, South Korea

[3] Ajou Univ, Sch Med, Dept Radiat Oncol, Suwon, South Korea

[4] Ajou Univ, Sch Med, Dept Pulm & Crit Care Med, Suwon, South Korea

来源：

KOREAN JOURNAL OF INTERNAL MEDICINE | 2022年 / 37卷 / 03期

关键词：

Head and neck neoplasms; Cisplatin; Chemoradiotherapy; Khorana score; VENOUS THROMBOEMBOLISM; RISK-FACTORS; CHEMOTHERAPY; THROMBOSIS;

D O I：

10.3904/kjim.2021.309

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background/Aims: The study investigated the incidence of thromboembolic events (TEE) in head and neck (H&N) cancer patients who received concurrent chemoradiotherapy (CCRT) with cisplatin, and analyzed the factors affecting TEE occur-rence Methods: Two hundred and fifty-seven patients who started CCRT with cisplatin for H&N cancer from January 2005 to De-cember 2019 were analyzed. Results: TEE occurred in five patients, an incidence rate of 1.9%. The 2-, 4-, and 6-month cumulative incidences of TEE were 0.8%, 1.6%, and 1.9%, respectively. Khorana score was the only factor associated with TEE occurrence (p = 0.010). Conclusions: The incidence of TEE in H&N cancer patients who underwent CCRT with cisplatin was relatively low when compared to other types of cancer. However, patients with a high Khorana score require more careful surveillance for possi-ble TEE occurrence.

引用

页码：653 / 659

页数：7

共 50 条

[41] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck [J].

Komatsu, Masanori ;

Shiono, Osamu ;

Taguchi, Takahide ;

Sakuma, Yasunori ;

Nishimura, Goushi ;

Sano, Daisuku ;

Sakuma, Naoko ;

Yabuki, Kenichiro ;

Arai, Yasuhiro ;

Takahashi, Masahiro ;

Isitoya, Junichi ;

Oridate, Nobuhiko .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) :416-421

[42] CONCURRENT CISPLATIN AND RADIATION VERSUS CETUXIMAB AND RADIATION FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER [J].

Koutcher, Lawrence ;

Sherman, Eric ;

Fury, Matthew ;

Wolden, Suzanne ;

Zhang, Zhigang ;

Mo, Qianxing ;

Stewart, Laschelle ;

Schupak, Karen ;

Gelblum, Daphna ;

Wong, Richard ;

Kraus, Dennis ;

Shah, Jatin ;

Zelefsky, Michael ;

Pfister, David ;

Lee, Nancy .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04) :915-922

[43] Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer [J].

Shirasu, Hiromichi ;

Yokota, Tomoya ;

Hamauchi, Satoshi ;

Onozawa, Yusuke ;

Ogawa, Hirofumi ;

Onoe, Tsuyoshi ;

Onitsuka, Tetsuro ;

Yurikusa, Takashi ;

Mori, Keita ;

Yasui, Hirofumi .

BMC CANCER, 2020, 20 (01)

[44] Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy [J].

Chou, Wen-Chi ;

Lai, Cheng-Chou ;

Hung, Chia-Yen ;

Hsueh, Shun-Wen ;

Yeh, Kun-Yun ;

Lu, Chang-Hsien ;

Tsang, Ngan-Ming ;

Chang, Pei-Hung ;

Ho, Ya-Wen ;

Chen, Shih-Ying ;

Lin, Yu-Ching ;

Hung, Yu-Shin .

CANCER CONTROL, 2022, 29

[45] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma A meta-analysis [J].

Tang, Wen-Hua ;

Sun, Wei ;

Long, Guo-Xian .

MEDICINE, 2020, 99 (36)

[46] Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients [J].

Otty, Zulfiquer ;

Skinner, Monika Buhrer ;

Dass, Joshua ;

Collins, Michael ;

Mooi, Jennifer ;

Thuraisingam, Kandeepan ;

Sabesan, Sabe .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (03) :287-292

[47] Adverse Events Associated With Concurrent Chemoradiation Therapy in Patients With Head and Neck Cancer [J].

Givens, Daniel J. ;

Karnell, Lucy Hynds ;

Gupta, Anjali K. ;

Clamon, Gerald H. ;

Pagedar, Nitin A. ;

Chang, Kristi E. ;

Van Daele, Douglas J. ;

Funk, Gerry F. .

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (12) :1209-1217

[48] Age-dependent hemato- and nephrotoxicity in patients with head and neck cancer receiving chemoradiotherapy with weekly cisplatin [J].

Weykamp, Fabian ;

Seidensaal, Katharina ;

Rieken, Stefan ;

Green, Kim ;

Mende, Stephan ;

Zaoui, Karim ;

Freier, Kolja ;

Adeberg, Sebastian ;

Debus, Juergen ;

Welte, Stefan Ezechiel .

STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (06) :515-521

[49] Dose density of weekly cisplatin delivered concurrent with radiotherapy in head and neck cancer patients [J].

Laidley, H. ;

Noble, D. ;

Barnett, G. ;

Benson, R. ;

Jefferies, S. ;

Gemill, J. ;

Burnet, N. .

CLINICAL ONCOLOGY, 2017, 29 :S6-S7

[50] Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer [J].

Shord, Stacy S. ;

Thompson, David M. ;

Krempl, Greg A. ;

Hanigan, Marie H. .

ANTI-CANCER DRUGS, 2006, 17 (02) :207-215

← 1 2 3 4 5 →